International Conference on Clinical Decision Support Systems aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results on all aspects of Clinical Decision Support Systems. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Clinical Decision Support Systems.

Read on waset.org

International Conference on Biocomposite Inks for 3D Printing and 3D Bioprinting aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Biocomposite Inks for 3D Printing and 3D Bioprinting. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Biocomposite Inks for 3D Printing and 3D Bioprinting.

Read on waset.org

This webinar will recommend strategies to efficiently execute pharma development & manufacturing programs. The speakers will discuss a real-life example about how appropriate planning and judicious risk assessment favorably impacted a project timeline for a virtual pharmaceutical company. The speakers will share the successful tactics that shortened the project by performing tasks in parallel, allowing the client to maintain their commitments to their stakeholders. They will also identify what risks to the timeline should be avoided.

Read on xtalks.dryfta.com

BIOMEDevice Silicon Valley, formerly known as BIOMEDevice San Jose, returns this winter. As Silicon Valley’s must-see regional event, biotech engineers and cutting-edge companies come together to preview the latest innovation in biotechnology and the solutions that are further pushing the boundaries of the industry.

Read on biomedevicesiliconvalley.com

Conference Series LLC Ltd invites the participants from all over the globe to attend Annual World Dentists Summit during November 29-30, 2022 Toronto, Canada. The theme of the conference is “Educating and Promoting Dental excellence across the Globe”. It will provide a global platform to discuss about the present and future challenges in dental education, continuing education, surgery, oral health and expertise meeting. Dentists summit 2022 focuses on recent innovations. This meeting will unite the Investigators, Instructors, Clinicians, Dental experts, Professors to give a global examination to the dispersing of one of a kind investigation results, new considerations and suitable change experiences which concentrate on both theory and practices in our Remedial social occasions.

Read on dentistssummit.conferenceseries.com

Population health is an increasingly clear and important priority for the health and care system and is key in addressing health inequalities. This is clear in the NHS Long Term Plan, in the 2022 Health and Care Act, and in the current and likely future policy landscape. A population health-led approach to health and care aims to improve physical and mental health outcomes, promote wellbeing and reduce health inequalities across an entire population. Whether you’re working in an integrated care system (ICS), primary care network, a national body, community group, or you’re someone with lived experience it is likely that you have been thinking about your own role in population health and how best you can help to improve the health and care of the people in your local area. This event will bring together those working in the NHS, public health, local authorities, the voluntary, community and social enterprise sector, and local communities to consider how best they can join the dots between work that is already under way and how to support others in their efforts to improve population health.

Read on kingsfund.org.uk

The pharma sector is a major contributor to global greenhouse gas emissions, with emission intensity being approximately 55 percent higher than that of the automotive sector. Global leaders in the pharmaceutical industry are prioritizing the elimination of harmful greenhouse gas emissions to limit global temperature to the 1.5-degree rise, as proposed in the Paris Climate Agreement of December 2015. The need to improve CO2 footprint in the pharmaceutical cold chain is now more than ever. 

In this webinar, Berlinger and South Pole discuss the impact of climate actions on the pharma cold chain market, the Berlinger and South Pole climate journey as well as how sustainability can add value to the respective business case. Berlinger argues that improving the ROI whilst reducing CO2 emissions in the pharmaceutical cold chain are not mutually exclusive.

Read on xtalks.dryfta.com

The pharma sector is a major contributor to global greenhouse gas emissions, with emission intensity being approximately 55 percent higher than that of the automotive sector. Global leaders in the pharmaceutical industry are prioritizing the elimination of harmful greenhouse gas emissions to limit global temperature to the 1.5-degree rise, as proposed in the Paris Climate Agreement of December 2015. The need to improve CO2 footprint in the pharmaceutical cold chain is now more than ever. From ambition to action, Berlinger has turned the challenge of high emissions in cold chain logistics into an opportunity for innovation. The company has developed an entirely new smart monitoring ecosystem “SmartSystem” meeting the various challenges of the industry among others real-time coverage, costs and sustainability. The basis for innovation is a baseline carbon footprint analysis of the Berlinger product portfolio. The project that was successfully completed with the renowned sustainability advisory South Pole in 2021 significantly impacted the innovation process of SmartSystem - in terms of hardware platform and respective business models - and resulted in the awarding of the Climate Neutral Product Label in 2022. In this webinar, Berlinger and South Pole discuss the impact of climate actions on the pharma cold chain market, the Berlinger and South Pole climate journey as well as how sustainability can add value to the respective business case. Berlinger argues that improving the ROI whilst reducing CO2 emissions in the pharmaceutical cold chain are not mutually exclusive.

Read on xtalks.com

HealthIL is the leading Healthcare Innovation Ecosystem in Israel, aiming to foster technological transformation in healthcare systems, both in Israel and globally. Our Mission is to improve healthcare by bridging the gap between the healthcare system and tech community.

Read on healthilweek.org

The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. As the field strives to strike a delicate balance between safety and efficacy, in the context of increased regulatory scrutiny and safety challenges, attending the 4th Annual Gene Therapy Analytical Development as an analytical scientist has never been so important.

This year’s summit returns in-person to Boston to reunite 300+ analytical experts in innovative biotech, pharma and academia to continue to develop resilient, long-lasting and robust analytical tools to enhance the safety, quality and efficacy of gene therapy products.

Whether you are focusing on specific characterization methods, enhancing your genome sequencing, advancing your understanding of full and partial particles, or advancing your early-stage bioassays, with 4 tracks, 8 pre-conference workshops and a post-conference focus day, the 4th Gene Therapy Analytical Development Summit will encompass all aspects of analytical development, giving you the chance to address and overcome challenges.

If you work in quality control, quality assurance, or process development - we’ve listened and we’ve answered. This year’s agenda includes a novel track designed for quality control and process development groups working in gene therapy. Talks include enhancing the knowledge transfer between departments, bridging between analytical methods with regards to QC/PD, and enhancing in-process development support.

Whether you're working with AAV, non-viral vectors or lentiviral vectors, this is your opportunity to enhance your existing analytical methods and explore innovative new tools to support safe and effective gene therapy development.